Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000630911 | SCV000751884 | likely benign | Fanconi anemia | 2024-12-12 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001756040 | SCV001988363 | uncertain significance | not provided | 2025-02-04 | criteria provided, single submitter | clinical testing | Reported as a variant of uncertain significance in an individual with pancreatic cancer (PMID: 28767289, 32659497); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 28767289, 32659497) |
St. |
RCV000630911 | SCV002032295 | uncertain significance | Fanconi anemia | 2021-11-17 | criteria provided, single submitter | clinical testing | The FANCA c.2029G>A (p.Val677Met) missense change has a maximum subpopulation frequency of 0.019% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org/variant/16-89838208-C-T?dataset=gnomad_r2_1). Six of seven in silico tools predict a benign effect of this variant on protein function (BP4), but to our knowledge these predictions have not been confirmed by functional assays. This variant has been reported in an individual with pancreatic ductal adenocarcinoma (PMID: 28767289), as well as in a non-cancer control individual (PMID: 29641532). To our knowledge, this variant has not been reported in individuals with Fanconi anemia. In summary, this variant meets criteria to be classified as of uncertain significance based on the ACMG/AMP criteria: BP4. |
Sema4, |
RCV000630911 | SCV002534937 | uncertain significance | Fanconi anemia | 2021-09-30 | criteria provided, single submitter | curation | |
Fulgent Genetics, |
RCV001271605 | SCV002800168 | uncertain significance | Fanconi anemia complementation group A | 2024-02-07 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001271605 | SCV001452872 | uncertain significance | Fanconi anemia complementation group A | 2020-09-16 | no assertion criteria provided | clinical testing |